0307 GMT - Sigma Healthcare's elevated profile from its impending merger with Chemist Warehouse and its likely inclusion as one of Australia's 100 largest listed companies earn the pharmaceutical supplier a new bull at Morgans. Analyst Scott Power raises his recommendation on the stock to add from hold, telling investors that Sigma will attract significant passive buying from funds if, as he expects, it is included in Australia's S&P/ASX 100 and other global indexes. He adds a 30% liquidity premium to his valuation as a result. Target price rises 35% to A$2.98. Shares are up 0.4% at A$2.68. (stuart.condie@wsj.com)
(END) Dow Jones Newswires
December 16, 2024 22:07 ET (03:07 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.